The Influence of Febuxostat on Coronary Artery Endothelial Dysfunction in Subjects With Chronic Stable Angina: A Phase 4 Randomized, Placebo-Controlled, Double-Blind, Cross-Over Study

Trial Profile

The Influence of Febuxostat on Coronary Artery Endothelial Dysfunction in Subjects With Chronic Stable Angina: A Phase 4 Randomized, Placebo-Controlled, Double-Blind, Cross-Over Study

Completed
Phase of Trial: Phase IV

Latest Information Update: 16 Apr 2016

At a glance

  • Drugs Febuxostat (Primary)
  • Indications Angina pectoris
  • Focus Pharmacodynamics
  • Sponsors Takeda; Takeda Global Research and Development Center
  • Most Recent Events

    • 10 Mar 2016 Status changed from active, no longer recruiting to completed.
    • 07 Jan 2015 Planned End Date changed from 1 Sep 2014 to 1 Apr 2015 according to ClinicalTrials.gov record.
    • 07 Jan 2015 Planned primary completion date changed from 1 Sep 2014 to 1 Apr 2015 according to ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top